ספלוטן

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

TAFLUPROST 15 MCG/ML

Mevcut itibaren:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodu:

S01EE05

Farmasötik formu:

OPHTHALMIC SOLUTION

Uygulama yolu:

OCULAR

Tarafından üretildi:

MERCK SHARP & DOHME B.V, HOLLAND

Terapötik grubu:

TAFLUPROST

Terapötik endikasyonlar:

Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.As monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyAs adjunctive therapy to beta-blockers.

Yetkilendirme tarihi:

2011-12-01